HIV/AIDS, Hepatitis, Infectious Disease News | STD Treatment …
RSV Vaccine Linked to Better Outcomes in Older Adults With IBD. Congenital Ichthyosis Is Associated With Viral, Fungal Cutaneous Infection Risk. Nitrofurantoin, Cranberry Products May Reduce UTI Episodes in Children. In a National First, an Idaho Health Department Is Refusing to Give COVID Vaccines.
IDSA AMR Guidance Update for Gram-Negative Infections
2024年9月20日 · IDSA 2024 Guidance on Antimicrobial-Resistant Gram-Negative Infections. The Infectious Diseases Society of America (IDSA) has issued updated guidance on the treatment of antimicrobial-resistant (AMR) gram-negative infections. The 2024 guidelines, which are an update to the 2023 guidelines, were published in Clinical Infectious Diseases.
Coagulase-Negative Staphylococcus - Infectious Disease Advisor
2024年2月16日 · Coagulase-negative staphylococci (CoNS) species are skin commensal bacteria typically encountered in hospital settings. 1 In the United States, they are the most common cause of health care-related infections. 2 There are more than 30 species of CoNS, and approximately 50% are known to colonize in humans. 2 Coagulase-negative staphylococci typically causes infection when there is a foreign ...
Myasthenia Gravis, Inflammatory Disorders Linked to COVID-19 …
2023年10月17日 · Cases of myasthenia gravis (MG) as a side effect of COVID-19 vaccination appear to be more frequent in patients over 50 years of age; symptoms tend to be similar to MG cases not associated with vaccination and usually resolve within 4 weeks, according to a recently published study in Medicine.. Although rare, inflammatory disorders such as MG have been reported as a side effect of COVID-19 ...
Updated C difficile Infection Clinical Guidance From IDSA/SHEA
2018年2月16日 · McDonald LC, Gerding DN, Johnson S, et al. Clinical practice guidelines for Clostridium difficile infection in adults and children: 2017 update by the Infectious Diseases Society of America (IDSA) and Society for Healthcare Epidemiology of America (SHEA) [published online February 15, 2018]. Clin Infect Dis. doi: 10.1093/cid/cix1085.
Review of 2023 IDSA Guidelines on AMR Gram-Negative ...
August 18, 2023. The Infectious Diseases Society of America (IDSA) has released updated guidelines on the treatment of antimicrobial-resistant (AMR) gram-negative infections. The updated guidance was published in Clinical Infectious Diseases. The updated guidelines cover preferred and alternative treatment options for 6 AMR gram-negative ...
Type O and Rh-Negative Blood Type Protective Against COVID-19
2021年1月13日 · The relative protective effects of O, Rh-, and O- blood groups were greatest in patients younger than age 70. Secondary outcome results indicated that type O blood group had an aRR of 0.87 (95% CI, 0.78-0.97) for severe COVID-19 illness and death versus all other blood groups and Rh- status had an aRR of 0.82 (95% CI, 0.68–0.96) compared to ...
Treponema Pallidum - Infectious Disease Advisor
2024年4月5日 · Treponema pallidum is a bacterium that causes syphilis, a sexually transmitted infection. 1 Formerly known as Spirochaeta pallida, T pallidum is a spirochete bacterium with a long, spiral shape. 2 Subspecies of T pallidum, which are morphologically indistinguishable from the pathogen that causes syphilis, can cause other conditions, including bejel and yaws. 2 This article focuses on T ...
IDSA Addresses Clinical Utility of COVID-19 Antibody Testing in …
2024年5月14日 · IDSA Addresses Clinical Utility of COVID-19 Antibody Testing in Updated Guidelines. The utility of measuring SARS-CoV-2 antibodies has declined as a public health strategy, with antibody testing now only recommended to assist with the diagnosis of multisystem inflammatory syndrome in children. There is limited utility in measuring anti-SARS-CoV ...
Complicated Intra-Abdominal Infections IDSA Update - Infectious …
August 23, 2024. The Infectious Diseases Society of America (IDSA) has released updated guidelines on the risk assessment, diagnostic imaging, and microbiologic evaluation of complicated intra-abdominal infections (IAIs). The new guidance was published in Clinical Infectious Diseases and is the first part of an expected 8-part series.